EOM Pharmaceutical (PK) Quote - IMUC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.1495

Bid

0.079

Ask

0.624

Volume

1,100

0.1051 Day's Range 0.1495

0.0182 52 Week Range 0.3999

Previous Close

0.1739

Open

0.1051

Last Trade

100

0.1495

Last Trade Time

Average Volume (3m)

1,802

Financial Volume

US$ 120

VWAP

0.109136

What were the results of the latest earnings call for EOM Pharmaceutical Holdings Inc (PK) (IMUC)?
What are the analysts ratings and price targets for EOM Pharmaceutical Holdings Inc (PK) (IMUC)?
Compare EOM Pharmaceutical Holdings Inc (PK) (IMUC) to its industry peers.
What is EOM Pharmaceutical Holdings Inc (PK) (IMUC) core business model and revenue streams?
Who are the top holders of EOM Pharmaceutical Holdings Inc (PK) (IMUC) stock?

Form RW - Registration Withdrawal Request

ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards

ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards PR Newswire LOS ANGELES, Oct. 17, 2018 LOS ANGELES, Oct. 17, 2018 /PRNewswire/...

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants Management Team to Transition to Consulting Roles in Effort to Streamline...

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results -Ongoing Exploration of Strategic Opportunities- -Continued Progress in Stem-to-T-Cell...

ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit

ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit Settlement Will Be Paid By Company's Insurance Carrier PR Newswire LOS ANGELES...

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results -Continued Progress in Stem-to-T-Cell Program- -Ongoing Exploration of Strategic Opportunities- PR Newswire LOS ANGELES...

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program PR Newswire LOS ANGELES, April 12, 2018 LOS ANGELES, April 12, 2018...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0555	-27.0731707317	0.205	0.205	0.105	910	0.17092863	CS
4	0.0705	89.2405063291	0.079	0.205	0.079	2047	0.16293459	CS
12	-0.0195	-11.5384615385	0.169	0.205	0.079	1802	0.12391962	CS
26	-0.0495	-24.8743718593	0.199	0.205	0.072	2371	0.1430389	CS
52	-0.1405	-48.4482758621	0.29	0.3999	0.0182	2867	0.19138816	CS
156	-0.3505	-70.1	0.5	0.94	0.0182	5312	0.37483555	CS
260	0.1105	283.333333333	0.039	0.98	0.0161	19744	0.17401485	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMPOQTempo Automation Holdings Inc (CE)	US$ 0.005 (499,900.00%)	100
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.0006 (59,900.00%)	268.14k
SWWISimon Worldwide Inc (GM)	US$ 0.0005 (49,900.00%)	300
AMMJAmerican Cannabis Company Inc (CE)	US$ 0.0004 (39,900.00%)	7.45k
MGTIMGT Capital Investments Inc (CE)	US$ 0.0002 (19,900.00%)	261.83k
CRMBQCrumbs Bake Shop Inc (CE)	US$ 0.000001 (-99.99%)	200
EMWPFEros Media World PLC (CE)	US$ 0.000001 (-99.95%)	100
CNONFLynx Global Digital Finance Corporation (CE)	US$ 0.000001 (-99.90%)	1.85k
DEERDeer Consumer Products Inc (CE)	US$ 0.000001 (-99.90%)	3.6k
CAFSCafe Serendipity Holdings Inc (CE)	US$ 0.000001 (-99.50%)	5k
HMBLHUMBL Inc (PK)	US$ 0.0003 (20.00%)	151.08M
ABQQAB International Group Corporation (PK)	US$ 0.001 (25.00%)	142M
THBDThird Bench Inc (PK)	US$ 0.0001 (0.00%)	128.56M
RDARRaadr Inc (PK)	US$ 0.001 (0.00%)	109.04M
ASTAAstra Veda Corporation (PK)	US$ 0.0002 (0.00%)	93.24M

OTC_Hussler 2 months ago

Look at all that money from the congregation give in loans. You would think they would want some return.

👍️0

Benwahsauce 2 months ago

Nevermind this one….
It should have taken off over 2 years ago and now it sits at bottom of the barrel.

Worst thing is it actually had a chance!

Now it’s bleeding out with paper cuts

👍️0

OTC_Hussler 3 months ago

Agreed. Haven’t bought in a long while. Holding 125k shares. I think the group behind this can make this go $3 or $4 easily if everything lines up. And uplist too. I’m sure they need a cash infusion though.

We shall see. Long over due for updates.

👍️0

Benwahsauce 3 months ago

I didn’t say buy…..just watching to see what’s going to happen. This one is interesting

👍️0

OTC_Hussler 3 months ago

What’s the reason for back on watch?

👍️0

Benwahsauce 3 months ago

Back on watch

👍️0

OTC_Hussler 5 months ago

One day…

👍️0

OTC_Hussler 6 months ago

Volume!

👍️0

OTC_Hussler 8 months ago

Way underwhelming financials. Guess it pays to be an insider Jew and get $0.20 shares

👍️0

OTC_Hussler 8 months ago

Move volume yesterday. Volume before price.

👍️0

OTC_Hussler 9 months ago

Some volume today!

👍️0

Benwahsauce 1 year ago

Well if said company buys and is worth more Money….then your not being diluted down on.

It’s more like you have less shares of a more valuable company.

And the valuations are not the market pricing….as that’s just what traders are willing to buy and sell for. The valuation comes in the form of actual tangible and intangible assets.

👍️0

OTC_Hussler 1 year ago

Agreed. Bought my first shares here in 2018 before IMUC fell apart. Have averaged down and kept buying. I had almost 7% of float before merger.

Still waiting. Just want to see something big happen here.

👍️0

Benwahsauce 1 year ago

I’m not a quick money trader, I suck at that.
I am however, an investor by trade.

The risk taken here with the common is worth the reward.

👍️0

OTC_Hussler 1 year ago

Yes sir. That’s over now. Thus the results need.

Where do you see them going from here?

👍️0

Benwahsauce 1 year ago

I believe that 30 day period is required

👍️0

OTC_Hussler 1 year ago

Haha. Nope. But there was a 30 day quiet period after canceling the funding raise.

Trial seems positive.

Not sure where they go from here but they have to have some funding plan to further trials.

They should be wrapping up testing on toxicity of their EOM613.

“Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation.”

👍️0

Benwahsauce 1 year ago

Do you work for them?

https://www.marketscreener.com/quote/stock/EOM-PHARMACEUTICALS-HOLDI-120790047/news/EOM-Pharmaceutical-Holdings-Announces-Topline-Results-of-its-COVID-19-Clinical-Trial-of-EOM613-in-Br-44781614/

👍️0

OTC_Hussler 1 year ago

Thinking news coming soon.

👍️0

Benwahsauce 1 year ago

When they merged with a larger company I assume the intentions were to help move this along faster as getting into phase 3 is not an easy task. So they must be close to something….

could be wrong so do not go off my judgement on this particular company

BUT

It seems like it doesn’t belong on the OTC at all.
I’ll leave it at that.

👍️0

OTC_Hussler 1 year ago

Like your positivity.

Per Irach in an email last week

Thanks for reaching out.

As you are possibly aware, the SEC rules specifically require that when a S-1 registration statement is put out there and still effective, a public company must maintain a 'quiet period" wherein a company's management and marketing teams cannot release any additional information or offer opinions on the firm than those which are present and contained in the registration statement. That explains the long silence and lack of news flow.

Now that the S-1 has been duly withdrawn, one may expect such information and updates to be released when available, with the caveat that there is an additional 30-day moratorium period after the S-1 has been withdrawn. One may therefore expect a news flow post that 30-day moratorium period.

Regards,
Irach

👍️0

Benwahsauce 1 year ago

Good for them.

Eventually this will be a big ordeal once they get everything in place.

Otherwise the Goldberg family will be out a lot of money. It makes more sense for this to take off anyways with a quite a few “possible” vaccinations going into phase 3 trail.

If that happens (it seems like two may get approved around same time….) this company will shoot up in value almost
10 fold.

But I’m never selling my shares.
Nobody needs to.

👍️0

OTC_Hussler 1 year ago

Any thoughts on them scrapping the up list and capital raising?

👍️0

OTC_Hussler 1 year ago

https://seekingalpha.com/news/3997205-eom-pharmaceuticals-shelves-plans-to-uplist-shares-raise-15m

👍️0

Benwahsauce 2 years ago

They have no say.

This I know for fact. If this were the case, then naked shorting would be the best and only play.

We all know that’s a mistake

👍️0

OTC_Hussler 2 years ago

Thanks for the tip Veteran. Haha. Anyways hope we make out like a bandit here one day. Patience I do have. Trust the process.

👍️0

Benwahsauce 2 years ago

Mad?

Too old for that

Never show your hand on ihub (of all places…)

Rookie mistake number 1.

👍️0

OTC_Hussler 2 years ago

Haha. How many you got? I showed mine and called you out. Seem like it made you mad.

👍️0

OTC_Hussler 2 years ago

Call TD and speak with them. They are “on order” and cannot legally be shorted. We all know how well they follow that rule.

👍️0

Benwahsauce 2 years ago

Also by keeping your shares that high in price….the lenders the can use them knowing it’s going to sit.

If you truly are an investor, this should be a walk in the park.

👍️0

Benwahsauce 2 years ago

Only proof I need is the amount of complaining and inexperience I see.
Especially with the amount of money you claim. Your pic is meaningless also. I can also change HTML coding…it’s not hard if you grew up in my era of the late 80’s early 90’s

So based off everything you’ve posted,
You should either not be investing at all…

OR

You work for a lender/investor that either wants more shares or wants us to sell them.

Either way never going to happen and that’s why I’m here to make sure of it.

👍️0

OTC_Hussler 2 years ago

I am holding 126,125 shares.

See link for proof. https://www.dropbox.com/sh/09afv937onxmurw/AACgWWag5cTz_fEj5EtRu39ga?dl=0

👍️0

Benwahsauce 2 years ago

Put your shares on there and I’ll take them all.

I have no problem waiting.

But honestly I don’t think you have the shares.

You’ve been trying to get us to sell for over a year now.

NEVER GOING TO HAPPEN.

Which lender are you working for?

👍️0

OTC_Hussler 2 years ago

Well not looking good. They cancelled their biggest trial. Back to waiting.

👍️0

OTC_Hussler 2 years ago

I agree this should rocket in price. Doesn’t look like they have raised the money yet. Perhaps a slow down with markets and banking fiasco.

S1 was amended and filed Dec 20 2022. https://www.otcmarkets.com/filing/html?id=16268613&guid=THA-kpnke4QtQth

Waiting for financials to drop and see what’s in them. They will have to have audited financials and be SEC reporting for the S1 to be live (or at least that’s my understanding).

Should happen sometime this year though.

I’ve called their number several times. About a month ago Irach Taraporewala actually answered. He didn’t have much to say but did confirm they were diligently working on data review to get news out.

No doubt they know how to raise funds and will time news with funding.

👍️0

Benwahsauce 2 years ago

NO THEORY.

Major increase in price coming.

They raised capital without issue and have 2 vaccines/IP on the table for phase 3.

That’s more than enough for me.

This could go at anytime after the long low volume sell off. And I feel that it’s only like this now due to market conditions. They got money at the right time before the rates skyrocketed.

👍️ 1

OTC_Hussler 2 years ago

Anybody have any theories here? What’s really going on?

👍️0

OTC_Hussler 2 years ago

Would love to see $10.00!

👍️0

Lowhndcpr 2 years ago

Slow accumulation been happening the past few months. Looking for great things here!

👍️0

Renee 2 years ago

ImmunoCellular Therapeutics Ltd. changed to EOM Pharmaceutical Holdings Inc.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

👍️0

OTC_Hussler 2 years ago

How long has VNDM been in the ask? They selling shares now?

👍️0

Benwahsauce 2 years ago

The valuation is what will change.

And most biotechs have huge multipliers

👍️0

OTC_Hussler 2 years ago

Possibly. But its going to depend on where they price those reg A shares. I think we have more waiting to do. But I would say conservative estimate is where they price those shares.

👍️0

Benwahsauce 2 years ago

$5.00 still too low.

👍️0

OTC_Hussler 2 years ago

Im looking for $5.00 here sooner than later.

👍️0

Benwahsauce 2 years ago

$1 is much too low.

This stock could go very big.
Like gap fills at $10+….

Some think I’m crazy (I mean I could be…)
But honestly…I’d be surprised if this isnt trading over the $1 range when they move a few phase 2’s into 3.

Phase 3’s can monetize and reap royalties very quickly OR they end up selling the patents and IP for millions. Either way it seems to me like this is very undervalued

👍️0

Lowhndcpr 2 years ago

Nice buys today. Hoping to be over a buck soon

👍️0

OTC_Hussler 2 years ago

Raised $750k with convertible note. https://www.sec.gov/Archives/edgar/data/822411/000149315222025629/xslFormDX01/primary_doc.xml

👍️0

OTC_Hussler 2 years ago

We’re going to laugh all the way to the bank here!

👍️0

Lowhndcpr 2 years ago

Nice to see myself in the green here finally. Shares are wanted. Holding mine to see what happens here. $1 plus will come shortly

👍️0

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EOM Pharmaceutical Holdings Inc (PK) (IMUC)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

IMUC Latest News

Form RW - Registration Withdrawal Request

ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018

Movers

IMUC Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EOM Pharmaceutical Holdings Inc (PK) (IMUC) Share Price

EOM Pharmaceutical Holdings Inc (PK) (IMUC)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

IMUC Latest News

Movers

IMUC Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%